from2028 Activists Investors Trump Politicians Serenity Citrini Burry Semianalysis Swing Trade Arbitrage Search

$PTGX:NASDAQ · Protagonist Therapeutics Inc - US

Sector: health

Conviction from: NASDAQCitrini

52-week range: 62.24160.81

Protagonist Therapeutics is a biopharmaceutical company that discovers and develops peptide-based therapies for inflammatory, blood, and other diseases.

3 tracked filer(s) hold this · 0 opened, 2 added, 1 trimmed in 30-JUN-2026

Aggregate 13FScore 71 — mean of 3 scored holder(s) · buyers (new/add) avg 76. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Stanley Druckenmiller / Duquesne	95	Added +31%	208,900	$25,607	0.5%
Bridgewater	56	Added +76%	9,269	$1,136,194	0.0%
Paul Tudor Jones / Tudor	63	Trimmed -42%	5,800	$710,964	0.0%

Beyond 13F — activists, insiders, politicians & research

Trump & executive branch trades all Trump/exec trades →

2 disclosed trade(s) by 1 filer(s).

Trade date	Who	Type	Amount
2026-09-22	Trump, Donald J President	SELL	$15,001 - $50,000	PTR
2026-07-01	Trump, Donald J President	SELL	$15,001 - $50,000	PTR

Citrini Research coverage report library →

Report	Date	Stance
#97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami	2025-05-28	LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.